Tag - RevBio

LaunchPad Medical Rebrands as RevBio and Launches an Updated Website

Ziad2022-11-25T14:02:28-05:00 Executives from LaunchPad Medical, Inc. announced that the company has rebranded. Its new name, RevBio, was chosen since it more accurately portrays the objective of developing its revolutionary Tetranite® bone adhesive biomaterial platform. Read more >>

LaunchPad Medical Initiates its First European Clinical Study

Ziad2022-11-25T14:02:28-05:00 LaunchPad Medical, Inc. announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient pilot clinical study to examine the safety and efficacy of Tetranite®, the company's bone adhesive biomaterial, to immediately stabilize dental implants following tooth extractions. Read more >>

LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant

Ziad2022-11-25T14:02:29-05:00 LaunchPad Medical, Inc. announced that it has received follow-on support of up to $1.8 million from the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center which was funded by the National Institute of Dental and Cranial Research (U24-DE029462) to improve the translation of promising tissue engineering and regenerative medicine technologies for dental, oral, and craniofacial clinical practice. Read more >>

LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures

Ziad2022-11-25T14:02:38-05:00 LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) from the National Institute of Neurological Disorders and Stroke to advance the development of Tetranite®, its bone adhesive biomaterial technology, to improve cranial flap fixation procedures. Read more >>

LaunchPad Medical Accelerates Enrollment in its First-In-Man Clinical Study

Ziad2022-11-25T14:02:40-05:00 LaunchPad Medical, Inc. announced that it has successfully enrolled half of the twenty patents approved by the FDA for its two-site pilot clinical study. This study constitutes the first clinical use of Tetranite®, a bone adhesive biomaterial. Read more >>

LaunchPad Medical Wins NIH HEAL Grant to Reduce Opioid Use and Addiction

Ziad2022-11-25T14:03:26-05:00 LaunchPad Medical, Inc. announced that it has received a grant from the National Institutes of Health through its Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, to improve strategies for the prevention and treatment for opioid misuse and addiction.Read more >>

Lowell-based company to start clinical trials on new dental glue

Ziad2022-11-25T14:03:26-05:00 The way we replace teeth and do dental work may never be the same thanks to a new, synthetic glue being tested by Lowell-based LaunchPad Medical. LaunchPad Medical was recently given approval by the U.S. Food and Drug Administration to do a two-site, 20-patient clinical study to examine the safety and efficacy of the company’s bone adhesive biomaterial glue that could immediately stabilize those who have undergone dental implants for tooth extractions. Read more >>

LaunchPad Medical Received FDA Approval to Initiate a Clinical Study

Ziad2022-11-25T14:03:26-05:00 LaunchPad Medical, Inc. has received approval from the U.S. Food and Drug Administration to initiate a two-site, 20-patient pilot clinical study to examine the safety and efficacy of the company's bone adhesive biomaterial (known as Tetranite®) to immediately stabilize dental implants for tooth extractions. Read more >>

Bone adhesive dev Launchpad Medical raises $9m | Medtech Funding Roundup

Ziad2022-11-25T14:03:39-05:00Launchpad Medical has raised $8.5 million in a new round of equity financing, according to recently posted SEC filings. Read more >>

U.S. Bone Glue Market is expected to grow with a CAGR of 6.7% | Global Industry Analysis by Cryolife, Luna Innovations Incorporated, Johnson and Johnson, Cohera Medical Inc., Tissuemed and C.R. Bard Inc.

Ziad2022-11-25T14:04:53-05:00Increased innovative technology for developing advanced in bone glue market to bring success in orthopaedic bone glue market over the forecast period. For instance, an emerging company LaunchPad Medical, LLC, is developing a product which in under trail is aInternational Space Station for experiments in microgravity environment, and the preclinical trial are been conducted. Mr. Brian Hess, CEO of Launch-Pad Medical, explains that this technology or product could replace the need for complicated surgeries of metal plates, screws and rods....